Page last updated: 2024-08-25

rosiglitazone and Cancer of Kidney

rosiglitazone has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brinkley, G; Buckhaults, P; Chandrashekar, DS; Karki, S; Kirkman, R; Kundu, A; Livi, CB; Mitchell, T; Nam, H; Rowe, GC; Shelar, S; Sudarshan, S; Tang, Y; Varambally, S; Wei, S	1

Other Studies

1 other study(ies) available for rosiglitazone and Cancer of Kidney

Article	Year
PRDM16 suppresses HIF-targeted gene expression in kidney cancer. The Journal of experimental medicine, 2020, 06-01, Volume: 217, Issue:6 Topics: Alcohol Oxidoreductases; Animals; Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Colforsin; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Membrane Glycoproteins; Mice; Mitochondria; Models, Biological; Phenotype; Promoter Regions, Genetic; Rosiglitazone; Semaphorins; Transcription Factors; Transcription, Genetic; Wound Healing; Xenograft Model Antitumor Assays	2020

Article

Year

PRDM16 suppresses HIF-targeted gene expression in kidney cancer.

The Journal of experimental medicine, 2020, 06-01, Volume: 217, Issue:6

Topics: Alcohol Oxidoreductases; Animals; Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Colforsin; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Membrane Glycoproteins; Mice; Mitochondria; Models, Biological; Phenotype; Promoter Regions, Genetic; Rosiglitazone; Semaphorins; Transcription Factors; Transcription, Genetic; Wound Healing; Xenograft Model Antitumor Assays

2020